Thelin sitaxsentan: Preliminary Phase IIb data

In a double-blind, U.S. Phase IIb trial in 35 evaluable patients, 33% and

Read the full 133 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE